Anchorage Capital Group’s Roivant Sciences ROIV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,832,642	Closed	-$54.5M	–	6
2025 Q2	$54.5M	Hold	4,832,642	–	–	21.05%	3
2025 Q1	$48.8M	Hold	4,832,642	–	–	19.5%	3
2024 Q4	$57.2M	Hold	4,832,642	–	–	20.12%	3
2024 Q3	$55.8M	Hold	4,832,642	–	–	14.6%	3
2024 Q2	$51.1M	Hold	4,832,642	–	–	15.77%	3
2024 Q1	$50.9M	Hold	4,832,642	–	–	13.26%	4
2023 Q4	$54.3M	Hold	4,832,642	–	–	6.46%	5
2023 Q3	$56.4M	Hold	4,832,642	–	–	8.58%	6
2023 Q2	$48.7M	Hold	4,832,642	–	–	7.29%	7
2023 Q1	$35.7M	Hold	4,832,642	–	–	5.51%	7
2022 Q4	$38.6M	Hold	4,832,642	–	–	4.95%	8
2022 Q3	$15.6M	Hold	4,832,642	–	–	1.39%	14
2022 Q2	$19.7M	Hold	4,832,642	–	–	1.97%	13
2022 Q1	$23.9M	Buy	+4,832,642	New	+$31.9M	1.62%	12